Cross-laboratory replication of pseudomyxoma peritonei tumor microbiome reveals reproducible microbial signatures.

IF 3.1 2区 生物学 Q2 MICROBIOLOGY mSphere Pub Date : 2025-03-25 Epub Date: 2025-02-20 DOI:10.1128/msphere.00652-24
Victoria F Nieciecki, Faith C Blum, Ryan C Johnson, Traci L Testerman, Tom J McAvoy, Mary Caitlin King, Vadim Gushchin, Jeannette M Whitmire, Kenneth G Frey, Lindsay Glang, Dessiree Peña-Gomez, Kimberly A Bishop-Lilly, Armando Sardi, D Scott Merrell, Jessica L Metcalf
{"title":"Cross-laboratory replication of pseudomyxoma peritonei tumor microbiome reveals reproducible microbial signatures.","authors":"Victoria F Nieciecki, Faith C Blum, Ryan C Johnson, Traci L Testerman, Tom J McAvoy, Mary Caitlin King, Vadim Gushchin, Jeannette M Whitmire, Kenneth G Frey, Lindsay Glang, Dessiree Peña-Gomez, Kimberly A Bishop-Lilly, Armando Sardi, D Scott Merrell, Jessica L Metcalf","doi":"10.1128/msphere.00652-24","DOIUrl":null,"url":null,"abstract":"<p><p>Recent work has demonstrated that cancer-specific microbial communities often colonize tumor tissues. However, untangling low-biomass signals from environmental contamination makes this research technically challenging. We utilize pseudomyxoma peritonei (PMP), a cancer characterized by the spread of mucus-secreting cells throughout the peritoneal cavity, to develop a robust workflow for identifying reproducible tumor microbiomes. Typically originating from the rupture of an appendiceal tumor into the peritoneal cavity, metastasized tumors have been previously shown to harbor a core set of microbes. However, that work did not control for the potential contamination of these low microbial biomass samples. We expand upon these prior findings by characterizing the microbiome of 70 additional PMP tumors and six normal peritoneal control tissues along with appropriate laboratory controls. Additionally, DNA from a subset of 25 tissues was extracted and sequenced at an independent laboratory. We found evidence of reproducible microbial signatures between the replicates of six different PMP tumors that include a set of core taxa that may be introduced from surgical contamination, as well as patient-specific taxa that are also commonly implicated in colorectal cancer. In addition, preoperative chemotherapy treatment was found to reduce tumor microbiome diversity. Our findings demonstrate how independent sample replication can be a powerful approach to investigate low-biomass microbial communities associated with tumor tissues that will improve low microbial biomass research.IMPORTANCERecent work has demonstrated that microbial communities colonize over 30 different types of tumor tissues. The origin of these communities and their possible involvement in carcinogenesis or cancer treatment outcomes remains an unclear, yet important area of research. A current major challenge in characterizing low-biomass, tumor-associated microbiomes is the introduction of environmental contamination during collection, handling, DNA extraction, PCR, and sequencing. Here, we provide a framework for replicating low-biomass tumor microbiome samples to help identify tumors with robust microbial signals and low background contamination. Using this replication approach, we show that pseudomyxoma peritonei (PMP) tumors host reproducible microbial communities, including organisms that have previously been associated with colorectal cancer. Incorporating sample replication into future tumor microbiome studies is a promising approach that will help identify robust signals and increase reproducibility in the field.</p>","PeriodicalId":19052,"journal":{"name":"mSphere","volume":" ","pages":"e0065224"},"PeriodicalIF":3.1000,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11934312/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"mSphere","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1128/msphere.00652-24","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/20 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Recent work has demonstrated that cancer-specific microbial communities often colonize tumor tissues. However, untangling low-biomass signals from environmental contamination makes this research technically challenging. We utilize pseudomyxoma peritonei (PMP), a cancer characterized by the spread of mucus-secreting cells throughout the peritoneal cavity, to develop a robust workflow for identifying reproducible tumor microbiomes. Typically originating from the rupture of an appendiceal tumor into the peritoneal cavity, metastasized tumors have been previously shown to harbor a core set of microbes. However, that work did not control for the potential contamination of these low microbial biomass samples. We expand upon these prior findings by characterizing the microbiome of 70 additional PMP tumors and six normal peritoneal control tissues along with appropriate laboratory controls. Additionally, DNA from a subset of 25 tissues was extracted and sequenced at an independent laboratory. We found evidence of reproducible microbial signatures between the replicates of six different PMP tumors that include a set of core taxa that may be introduced from surgical contamination, as well as patient-specific taxa that are also commonly implicated in colorectal cancer. In addition, preoperative chemotherapy treatment was found to reduce tumor microbiome diversity. Our findings demonstrate how independent sample replication can be a powerful approach to investigate low-biomass microbial communities associated with tumor tissues that will improve low microbial biomass research.IMPORTANCERecent work has demonstrated that microbial communities colonize over 30 different types of tumor tissues. The origin of these communities and their possible involvement in carcinogenesis or cancer treatment outcomes remains an unclear, yet important area of research. A current major challenge in characterizing low-biomass, tumor-associated microbiomes is the introduction of environmental contamination during collection, handling, DNA extraction, PCR, and sequencing. Here, we provide a framework for replicating low-biomass tumor microbiome samples to help identify tumors with robust microbial signals and low background contamination. Using this replication approach, we show that pseudomyxoma peritonei (PMP) tumors host reproducible microbial communities, including organisms that have previously been associated with colorectal cancer. Incorporating sample replication into future tumor microbiome studies is a promising approach that will help identify robust signals and increase reproducibility in the field.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
腹膜假性黏液瘤肿瘤微生物组的跨实验室复制揭示了可复制的微生物特征。
最近的研究表明,癌症特异性微生物群落经常在肿瘤组织中定植。然而,从环境污染中解开低生物量信号使这项研究在技术上具有挑战性。我们利用腹膜假性黏液瘤(PMP),一种以粘液分泌细胞在整个腹膜腔内扩散为特征的癌症,来开发一个强大的工作流程来识别可复制的肿瘤微生物群。通常起源于阑尾肿瘤破裂进入腹膜腔,转移性肿瘤先前已被证明含有一组核心微生物。然而,这项工作并没有控制这些低微生物生物量样品的潜在污染。我们通过表征70个额外的PMP肿瘤和6个正常腹膜对照组织的微生物组以及适当的实验室对照,扩展了这些先前的发现。此外,从25个组织的一个子集中提取DNA并在一个独立的实验室进行测序。我们在六种不同的PMP肿瘤的重复中发现了可重复的微生物特征的证据,这些肿瘤包括一组可能从手术污染中引入的核心分类群,以及通常与结直肠癌有关的患者特异性分类群。此外,发现术前化疗可降低肿瘤微生物群的多样性。我们的研究结果表明,独立样本复制是研究与肿瘤组织相关的低生物量微生物群落的有力方法,这将改善低微生物生物量的研究。最近的研究表明,微生物群落在30多种不同类型的肿瘤组织中定植。这些群体的起源及其可能与致癌或癌症治疗结果的关系仍然是一个不清楚的重要研究领域。目前表征低生物量肿瘤相关微生物组的主要挑战是在收集、处理、DNA提取、PCR和测序过程中引入环境污染。在这里,我们提供了一个复制低生物量肿瘤微生物组样本的框架,以帮助识别具有强大微生物信号和低背景污染的肿瘤。使用这种复制方法,我们发现腹膜假粘液瘤(PMP)肿瘤具有可复制的微生物群落,包括以前与结直肠癌相关的生物。将样本复制纳入未来的肿瘤微生物组研究是一种很有前途的方法,将有助于识别强大的信号并提高该领域的可重复性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
mSphere
mSphere Immunology and Microbiology-Microbiology
CiteScore
8.50
自引率
2.10%
发文量
192
审稿时长
11 weeks
期刊介绍: mSphere™ is a multi-disciplinary open-access journal that will focus on rapid publication of fundamental contributions to our understanding of microbiology. Its scope will reflect the immense range of fields within the microbial sciences, creating new opportunities for researchers to share findings that are transforming our understanding of human health and disease, ecosystems, neuroscience, agriculture, energy production, climate change, evolution, biogeochemical cycling, and food and drug production. Submissions will be encouraged of all high-quality work that makes fundamental contributions to our understanding of microbiology. mSphere™ will provide streamlined decisions, while carrying on ASM''s tradition for rigorous peer review.
期刊最新文献
Within-patient evolution of Pseudomonas aeruginosa populations during antimicrobial treatment. Planning for the future of the American Society for Microbiology's Health Unit by the Council on Microbial Sciences. Evolutionary dynamics and virulence factor variability in invasive Streptococcus pyogenes in Norway, 2017-2023. Transcriptomic analysis of tigecycline-induced colistin collateral sensitivity in carbapenem-resistant Enterobacter cloacae complex. mSphere of Influence: The power of in situ-structural biology without leaving "home".
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1